Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer

NCT04515004 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04515004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04515004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Terminated
Start date
November 20, 2023
Completion date
March 31, 2025
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early stage lung cancer (i and ii)